CN Patent

CN104027791B — 药物组合物

Assigned to Zhejiang Hisun Pharmaceutical Co Ltd · Expires 2016-08-10 · 10y expired

What this patent protects

本发明涉及用于抗辐射辅助用药或抗肿瘤药物辅助用药的活性组分的具有式I所示CBLB612及其药学上可接受盐的药物冻干组合物。所述的组合物还包括特定的赋形剂和稳定pH范围的pH调节剂或缓冲盐体系。本发明所述的组合物显示出好的稳定性和医学效果，又便于运输和储藏。 式I。

USPTO Abstract

本发明涉及用于抗辐射辅助用药或抗肿瘤药物辅助用药的活性组分的具有式I所示CBLB612及其药学上可接受盐的药物冻干组合物。所述的组合物还包括特定的赋形剂和稳定pH范围的pH调节剂或缓冲盐体系。本发明所述的组合物显示出好的稳定性和医学效果，又便于运输和储藏。 式I。

Drugs covered by this patent

Patent Metadata

Patent number
CN104027791B
Jurisdiction
CN
Classification
—
Expires
2016-08-10
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Hisun Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.